Accelerate Diagnostics Valuation
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
Accelerate Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Accelerate Diagnostics from analyzing the firm fundamentals such as current valuation of 50.42 M, and Return On Asset of -0.74 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Accelerate Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Accelerate Diagnostics is based on 3 months time horizon. Increasing Accelerate Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Accelerate Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Accelerate Stock. However, Accelerate Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.04 | Real 0.038 | Hype 0.036 |
The intrinsic value of Accelerate Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Accelerate Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Accelerate Diagnostics helps investors to forecast how Accelerate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Accelerate Diagnostics more accurately as focusing exclusively on Accelerate Diagnostics' fundamentals will not take into account other important factors: Accelerate Diagnostics Total Value Analysis
Accelerate Diagnostics is presently forecasted to have valuation of 50.42 M with market capitalization of 859.92 K, debt of 66.58 M, and cash on hands of 36.77 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Accelerate Diagnostics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
50.42 M | 859.92 K | 66.58 M | 36.77 M |
Accelerate Diagnostics Investor Information
About 38.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.15. Accelerate Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 12th of July 2023. Based on the key indicators related to Accelerate Diagnostics' liquidity, profitability, solvency, and operating efficiency, Accelerate Diagnostics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Accelerate Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Accelerate Diagnostics has an asset utilization ratio of 40.97 percent. This suggests that the Company is making $0.41 for each dollar of assets. An increasing asset utilization means that Accelerate Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.Accelerate Diagnostics Ownership Allocation
Accelerate Diagnostics holds a total of 25.29 Million outstanding shares. Accelerate Diagnostics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Accelerate Diagnostics Profitability Analysis
The company reported the previous year's revenue of 11.7 M. Net Loss for the year was (50.05 M) with profit before overhead, payroll, taxes, and interest of 2.7 M.About Accelerate Diagnostics Valuation
Our relative valuation model uses a comparative analysis of Accelerate Diagnostics. We calculate exposure to Accelerate Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Accelerate Diagnostics's related companies.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnosti operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 220 people.
Accelerate Diagnostics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 23.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |